News and Comments

Ariad’s (ARIA) ridaforolimus Brings Hope To Advanced Endometrial Cancer Patients.

  Monday, November 22, 2010

Endometrial cancer is the most common cancer of the female reproductive system. Advanced cases have virtually no effective treatments. Surgery, alone or in combination with radiation, chemotherapy, and/or hormonal therapy are good as initial therapy. In advanced stages, however, surgery has no role to play and chemotherapy has limited, if any, benefit.  More...


Recent Postings


Archive


Tags

Ziofpharm (ZIOP) Dendreon (DNDN) Sanofi-Aventis (SAN) Galena (GALE) IDERA (IDRA) ADVENTRIX (ANX) Sangamo (SGMO) Gilead (GILD) Bristol-Myers Squibb (BMY) Telaprevir Prosensa (RNA) Merck (MRK) Intermune (ITMN) AERIE PHARMACEUTICALS OSI (OSIP) ImmunoGen (IMGN) Intercept (ICPT) Illumina (ILMN) Abbott Laboratories (ABT) Cytokinetics (CYTK) Endometrial Cancer Tysabri Zerenex Aimmune Therapeutics (AIMT) Sanofi (SNA) C4 Therapeutics galapagos (GLPG) Theravance (THRX) GlaxoSmithKline (GSK) BIOMARIN (BMRN) Idenix (IDIX) Inovio (INO) SERES THERAPEUTICS (MCRB) Prolor Biotech (PBTH) Agenus (AGEN Human Genome Sciences (HGSI) GUARDIAN HEALTH KITE (KITE) ISIS (ISIS) Vertex (VRTX) Ariad (ARIA) Amgen (AMGN) Sequenom (SQNM) Roche (ROCHE) VANDA (VNDA) Onyx (ONXX) ARCA (ABIO) Rapamune ZALTRAP™ NANTKWEST (NK) Mirati Therapeutics (MRTX) Array Pharmaceuticals (ARRY) KERYX (KERX) HALOZYME (HALO) ABBVIE (ABBV) Trastuzumab-DM1 Incyte (INCY) JUNO (JUNO) Regeneron (REGN) Genentech Exelixis (EXEL) Auspex (ASPX) Benlysta (belimumab) Roche (RHHBY) Micromet (MITI) Elan (ELN) Herceptin Multiple Myeloma Agenus (AGEN) Ridaforolimus Revlimid (lenolidamide) CompuGen (CGEN) Sarepta (SRPT) Jazz Pharmaceuticals (JAZZ) Velcade (bortezomib) TOKAI (TKAOI) Sanofi (SNY) NEKTAR (NKTR)) Xoma (XOMA) Biogen Idec (BIIB) Pluristem (PSTI) SUNESIS PHARMACEUTICALS (SNSS) Intrexon (XON) Biocryst (BCRX) Anacor (ANAC) SYNTA (SNTA) Seattle Genetics (SGEN) Anadys (ANDS) Dynavax (DVAX) Valeant Pharmaceuticals International (VRX) Alnylam (ALNY)